Clinical Trial Update: Study of LC23-1306 in Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial of LC23-1306 in healthy male subjects completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• LC23-1306

Snippet

Sponsor: LG Life Sciences | Conditions: Acute Coronary Syndrome | Phase 1 | Status: COMPLETED | Results posted: 2018-08-13